Removing high-grade squamous intraepithelial lesions reduces chances of progression to anal cancer

By | October 8, 2021
In a randomized clinical trial with 4,446 participants, known as the Anal Cancer/HSIL Outcomes Research (ANCHOR) study, researchers found that by removing high-grade squamous intraepithelial lesions (HSIL), chances of progression to anal cancer were significantly reduced.